课题基金 / 基金详情

Improving care for cohesinopathies: from heart phenotypes to novel therapies

Improving care for cohesinopathies: from heart phenotypes to novel therapies
改善粘连病的护理:从心脏表型到新疗法
批准号:
332057
负责人:
Andelfinger Gregor U
金额:
$23.68万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-06-01 至 2018-06-01

项目摘要

项目成果

Andelfinger Gregor U的其他基金

相似基金

相关文献

中文摘要
翻译
当身体中的细胞生长并做出决定时,比如它们分裂的速度有多快,或者它们为自己的发育选择了什么命运,它们需要阅读和解释遗传密码。这一过程是由一种叫做粘附素复合体的蛋白质推动的。当
英文摘要
When cells in the body grow and take decisions such as how fast they divide or which fate they choose for their development, they need to read and interpret the genetic code. This process is facilitated by proteins that are called the cohesin complex. Whe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the Adamts19-dependent mechanisms that regulate valve maturation
Weinstein Cardiovascular Development Conference 2020
Role of shugoshin-like 1 (SGOL1) in heart development
Genetic and functional dissection of a novel pacemaking syndrome: a model for SGOL1 mutations
海外基金